• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Upgrade of revenue and operating profit guidance

    GLOBENEWSWIRE

    ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA

    GLOBENEWSWIRE

    Procedure of the Annual General Meeting

    GLOBENEWSWIRE

    Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer

    ACCESSWIRE

    FDA commissioner heralds end to US shortfall of chemo drug cisplatin

    FIERCE PHARMA

    Chemo`s Generic Estradiol Receives Approval in the U.S.

    FDA

    FDA shoots down pe­ti­tion to stall gener­ic ver­sions of chemo Abrax­ane

    ENDPTS

    Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III

    CONTRACTPHARMA

    Chemo for glioblastoma may work better in morning than evening

    SCIENCEDAILY

    Chemo Group opens plant in Hyderabad with Rs 100 cr investment

    BUSINESS-STANDARD

    U.S. FDA Approves Chemo Group`s Benznidazole Treat Children with Chagas Disease

    PR NEWSWIRE

    U.S. FDA approves chemo group`s benznidazole to treat children Chagas disease

    BIOSPECTRUM

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.